Target audience: Scientists, Physicians, Patients, Medical Students, Residents, Fellows, Pharmacists, Biologists, NursesAims and scope: The journal "Frontiers in Bioscience" is a modern forum for scientific communication. Data and information that are useful to investigators in any discipline in biology and medicine including Biochemistry, Microbiology, Parasitology, Virology, Immunology, Biotechnology, And Bioinformatics will be published after they have been peer reviewed. This will include reviews and research articles in basic science and clinical science, as well as technical notes and protocols. Other materials that have not been traditionally published as peer reviewed articles will also be considered for publication. This will include, rare images ,videos and sounds, and assimilated data in the form of a database on any subject in medicine and biology. The journal will include useful search strategies of internet and databases related to biology and medicine, links to medically relevant journals and the guidelines to authors of scientific journals and as well as information regarding manufacturers' products and links to manufacturers' homepages.Other items that will be posted are book reviews, as well as a list of conferences.
Functional & Integrative Genomics is devoted to large-scale studies of genomes and their functions, including systems analyses of biological processes. Topics covered include: - Whole genome analyses/bioinformatics/expression profiling - Genomics (structural, comparative, integrative) - Proteomics and Metabolomics (integrated with function) - Metagenomics - Human disease genes and loci - Large-scale/high throughput analysis of biological systems Emphasis will be placed on manuscripts addressing important biological problems using large-scale systems and approaches. Studies on bacterial, fungal, protista, plant and animal genomes are welcome. Papers describing new techniques will only be considered for publication if they are sufficiently novel and broadly applicable.
Fungal Biology is the international research journal of the British Mycological Society. Fungal Biology publishes original contributions in all fields of basic and applied research involving fungi and fungus-lke organisms (including filamentous fungi, yeasts, lichen fungi, oomycetes, and slime moulds). These fields include biochemistry, biodeterioration, biotechnology, cell biology, developmental biology, disease control, ecology, environment, evolution, fungal physiology, genetics, genomics, geomycology, insect pathology, medical mycology, molecular genetics, mutualistic interactions, physiology, plant pathology, secondary metabolites, taxonomy and systematics, and techniques. Priority is given to contributions likely to be of interest to a wide international audience.
Fungal Genetics and Biology, formerly known as Experimental Mycology, publishes experimental investigations of fungi and their traditional allies that relate structure and function to growth, reproduction, morphogenesis, and differentiation. This journal especially welcomes studies of gene organization and expression and of developmental processes at the cellular, subcellular, and molecular levels. The journal also includes suitable experimental inquiries into fungal cytology, biochemistry, physiology, genetics, and phylogeny.Fungal Genetics and Biology publishes basic research conducted by mycologists, cell biologists, biochemists, geneticists, and molecular biologists.Research Areas include:• Biochemistry• Cytology• Developmental biology• Evolutionary biology• Genetics• Molecular biology• Phylogeny• PhysiologyPlease note: the Journal does not accept manuscripts based solely on microarrays, or manuscripts based solely on in silico analyses of EST libraries, subtraction hybridization libraries etc. which are not supported by additional functional biology experiments, unless they can demonstrate findings of outstanding novelty and importance.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services .Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com
Future Cardiology reflects a new era of cardiology and highlights the new molecular approach to advancing cardiovascular therapy. Coverage also reflects the major technological advances in bioengineering in cardiology in terms of advanced and robust devices, miniaturization, imaging, system modeling and information management issues. We also take a new approach to the way information is structured and delivered, so that its value is maximized to the reader. Future Cardiology provides a forward-looking, authoritative perspective with a readily accessible format to inform future clinical practice in cardiovascular care. Integrated molecular approaches will have a great impact on cardiovascular healthcare in the future. However, the expense of such treatments viewed alongside the increasingly aging population will require a fundamental review of how this care is provided, and exploration of their relevance in the clinical setting, to inform future clinical practice in cardiovascular care.
Medicinal chemistry has evolved rapidly into a highly interdisciplinary field, enriched by the collaborative efforts of experts from a wide spectrum of specialist areas, from chemoinformaticians and physical chemists to molecular biologists and pharmacologists. Future Medicinal Chemistry provides a monthly point of access to commentary and debate for this ever-expanding and diversifying community. The journal showcases milestones in pharmaceutical R&D and features expert analysis of emerging research, from the identification of targets, through to the discovery, design, synthesis and evaluation of bioactive agents.
Future Oncology takes a forward-looking stance toward the scientific and clinical issues, together with the economic and policy issues that confront us in a new era of cancer care. The journal includes news and views, literature awareness regarding new biomarkers, concise commentary and analysis, reports from the conference circuit and full review articles. Accessible ‘at-a-glance’ formats are important in an increasingly time-constrained clinical community. The article structure has been optimized to make information immediately understandable and accessible.